Hidetake Kawajiri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hidetake Kawajiri has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Hitoshi Yaku
Department of Cardiovascular Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
3 shared publications - Satoshi Numata
Department of Cardiovascular Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
3 shared publications Kaichiro Manabe
Department of Cardiovascular Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
2 shared publications- Koki Ikemoto
Department of Cardiovascular Surgery, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, Japan
2 shared publications - Sachiko Yamazaki
Bunkyo Gakuin University, Saitama, Japan
2 shared publications - Fumimasa Amaya
Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan
1 shared publication
Latest Publications
- 26 April 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (6) , 1211-1218
Point-of-care testing for tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients
- 26 April 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (6) , 1211-1218
Point-of-care testing for tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients
- Open Access
- 1 October 2022
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 29 (5) , 2652-2663
Serial changes in cardiac sympathetic nervous function after transcatheter aortic valve replacement: A prospective observational study using 123I-meta-iodobenzylguanidine imaging
- 1 October 2022
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 29 (5) , 2652-2663
Open AccessSerial changes in cardiac sympathetic nervous function after transcatheter aortic valve replacement: A prospective observational study using 123I-meta-iodobenzylguanidine imaging
- Open Access
- 15 February 2022
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 35 (2) , 239-248
Effect of Left Ventricular Hyperenhancement in Magnetic Resonance Imaging on Reverse Remodeling After Mitral Valve Repair for Moderate Ischemic Mitral Regurgitation
- 15 February 2022
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 35 (2) , 239-248
Open AccessEffect of Left Ventricular Hyperenhancement in Magnetic Resonance Imaging on Reverse Remodeling After Mitral Valve Repair for Moderate Ischemic Mitral Regurgitation
- Open Access
- 28 June 2016
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 50 (4) , 704-712
Ventricular volume and myocardial viability, evaluated using cardiac magnetic resonance imaging, affect long-term results after surgical ventricular reconstruction
OBJECTIVES We aimed to investigate the outcomes of surgical ventricular reconstruction (SVR) for ischaemic cardiomyopathy and to identify ideal candidates for this procedure using cardiac magnetic resonance imaging (MRI) studies. METHODS We retrospectively examined 50 patients who underwent SVR and were preoperatively evaluated using cardiac MRI from 2004 to 2014. Cine MRI and gadolinium-enhanced MRI were performed to evaluate left ventricular (LV) volume and scarring. The midterm (median, 2.5 years) risk factors of cardiac death or major adverse cardiac events (MACEs) were analysed. Patients were divided into three groups—those with preoperative indexed LV end-systolic volume (LVESVI) of ≤100 ml/m2 (Group 1), those with LVESVI of >100 and ≤130 ml/m2 (Group 2) and those with LVESVI of >130 ml/m2 (Group 3)—and examined. RESULTS In total, 17 patients exhibited MACEs at follow-up. Kaplan–Meier analysis showed that the 5-year rate of freedom from MACEs was 66%. The Cox hazard model indicated that preoperative LVESVI was the only significant predictor for MACEs (P = 0.006; hazard ratio, 1.02; 95% confidence interval, 1.01–1.04). Moreover, a significant reduction in LVESVI and an increase in LV ejection fraction (LVEF) were observed early after SVR (preoperative versus postoperative: LVESVI, 110 ± 44 vs 68 ± 28 ml/m2, P < 0.001; LVEF, 24.3 ± 10.3 vs 32.0 ± 10.4%, P < 0.001) and at follow-up (LVESVI, 61 ± 28 ml/m2, P < 0.001; LVEF, 36.5 ± 11.5%, P < 0.001). Although no difference was observed between the groups at follow-up, LVEF and LVESVI primarily improved in Group 2. LVEF improvement was significantly greater in Group 2 than in Group 1 (%increase in LVEF: Group 1, 6%; Group 2, 18%; P = 0.008). In patients with a preoperative LVESVI of >130 ml/m2, the number of non-viable segments was a significant risk factor for MACEs. CONCLUSIONS Patients with preoperative LVESVI ranging from 100 to 130 ml/m2 had fairly better outcomes, and the percentage improvement in LVEF and the percentage reduction in LVESVI were more pronounced in these patients. Hence, accurate preoperative assessments of LV volume and viability testing using cardiac MRI studies are essential for better stratification of the SVR procedure.
- 28 June 2016
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 50 (4) , 704-712
Open AccessVentricular volume and myocardial viability, evaluated using cardiac magnetic resonance imaging, affect long-term results after surgical ventricular reconstruction
OBJECTIVES We aimed to investigate the outcomes of surgical ventricular reconstruction (SVR) for ischaemic cardiomyopathy and to identify ideal candidates for this procedure using cardiac magnetic resonance imaging (MRI) studies. METHODS We retrospectively examined 50 patients who underwent SVR and were preoperatively evaluated using cardiac MRI from 2004 to 2014. Cine MRI and gadolinium-enhanced MRI were performed to evaluate left ventricular (LV) volume and scarring. The midterm (median, 2.5 years) risk factors of cardiac death or major adverse cardiac events (MACEs) were analysed. Patients were divided into three groups—those with preoperative indexed LV end-systolic volume (LVESVI) of ≤100 ml/m2 (Group 1), those with LVESVI of >100 and ≤130 ml/m2 (Group 2) and those with LVESVI of >130 ml/m2 (Group 3)—and examined. RESULTS In total, 17 patients exhibited MACEs at follow-up. Kaplan–Meier analysis showed that the 5-year rate of freedom from MACEs was 66%. The Cox hazard model indicated that preoperative LVESVI was the only significant predictor for MACEs (P = 0.006; hazard ratio, 1.02; 95% confidence interval, 1.01–1.04). Moreover, a significant reduction in LVESVI and an increase in LV ejection fraction (LVEF) were observed early after SVR (preoperative versus postoperative: LVESVI, 110 ± 44 vs 68 ± 28 ml/m2, P < 0.001; LVEF, 24.3 ± 10.3 vs 32.0 ± 10.4%, P < 0.001) and at follow-up (LVESVI, 61 ± 28 ml/m2, P < 0.001; LVEF, 36.5 ± 11.5%, P < 0.001). Although no difference was observed between the groups at follow-up, LVEF and LVESVI primarily improved in Group 2. LVEF improvement was significantly greater in Group 2 than in Group 1 (%increase in LVEF: Group 1, 6%; Group 2, 18%; P = 0.008). In patients with a preoperative LVESVI of >130 ml/m2, the number of non-viable segments was a significant risk factor for MACEs. CONCLUSIONS Patients with preoperative LVESVI ranging from 100 to 130 ml/m2 had fairly better outcomes, and the percentage improvement in LVEF and the percentage reduction in LVESVI were more pronounced in these patients. Hence, accurate preoperative assessments of LV volume and viability testing using cardiac MRI studies are essential for better stratification of the SVR procedure.